Abbvie
Samantha Neville
Field Access Specialist - Northeast
Cell:(727) 401-9924
Venclexta https://www.venclexta.com/cll/support-and-resources/financial-support.html

GlaxoSmithKline
Michael Savoia
Northeast Oncology FRM
Managed Markets & Government Affairs
5 Moore Drive, PO Box 13398, RTP, NC 27709-3398
United States
Email michael.j.savoia@gsk.com
Cell 914-588-3473
www.togetherwithgskoncology.com

Guardant Health

Bryan Lorenz

Regional Sales Director, Northeast

Phone 716-901-1419

Email: blorenz@guardanthealth.com

https://guardant360cdx.com/practice-resources/

Agios Pharmaceuticals
Phillip Ricci
Senior Manager Patient Access & Reimbursement Services
Cell Phone: (781) 258-7464

Email: phillip.ricci@agios.com

Tibsovo (ivosidenib)
Patient Support Services:
www.myagios.com/patient/index.html
Copay Assistance: www.myagios-copay.com/#/app/layout/home

Heron Therapeutics
Michelle Wollersheim
Director, National Accounts /Reimbursement
C: 414-687-5624
E: mwollersheim@herontx.com

CINVANTI® (aprepitant) injectable emulsion
SUSTOL® (granisetron) extended-release injection

https://www.heronconnect.com/

Incyte

Maura (Eichman) Sandell, BSN

Oncology Therapeutic Specialist

Incyte Corporation

msandell@incyte.com

603-718-9295

IncyteCARES: http://www.jakafi.com/hcp/incytecares-support-program.aspx

Feraheme Assist

Feraheme IV Iron

Mariaelena Galie

Senior Manager, Patient Services

mgalie@amahpharma.com

267-275-1185

https://www.feraheme.com/patient-support/

Ipsen
Melissa Kramer
Regional Reimbursement Director
978-701-8568
Email:melissa.kramer@ipsen.com

Somatuline Depot(Lanreotide),  and Onivyde(Irinotecan Liposome Injection)

Amgen
Trish Hanson
781-815-2694
Tricia.Hansen@xcenda.com
Amgen Assist
1-704-618-6767

Janssen 
Ward Bennett
Healthcare Policy and Advocacy Director
Strategic Customer Group
Johnson & Johnson
Health Care Systems Inc.
8 Bloody Brook Rd
Amherst NH 03031 USA
T: 603-672-9381
M: 603-345-1404
wbennett@its.jnj.com
http://www.janssencarepath.com/
DARZALEX® (daratumumab), YONDELIS® (trabectedin), ZYTIGA® (abiraterone acetate), DOXIL® (doxorubicin HCl liposome injection), PROCRIT® (epoetin alfa), and SYLVANT® (siltuximab),ERLEADA® (apalutamide).

Astellas
Kevin Kobylinski
Access and Reimbursement Manager
NH/VT/ME/MA/CT/RI
C: 603-502-8175
E-mail: kevin.kobylinski@Astellas.com 
PADCEV™ (enfortumab vedotin-ejfv), Xospata® (gilteritinib), Xtandi® (enzalutamide) 
https://www.astellaspharmasupportsolutions.com/

Jazz Pharmaceuticals 
Lynn Monte
Access & Reimbursement Manager
Hematology/Oncology
Jazz Pharmaceuticals
3170 Porter Drive
Palo Alto, CA 94304
508-873-1445
Lynn.monte@jazzpharma.com
www.jazzcares.com

AstraZeneca/MedImmune 

Aveo Oncology

Caroline Ward, RN, BSN

Oncology Account Manager-New England

cward@aveooncology.com

603-707-6223

Product: Fotivda (tivozanib)

AVEO ACE Program- Access Center of Excellence

www.fotivda.com to enroll

1-833-Fotivda (1-833-368-4832)

Lilly USA
Mary E. Mergy, MBA
Oncology Field Reimbursement Manager – Northeast
(Eli Lilly and Company
Lilly Technology Center South, Indianapolis, IN 46285
314.601.7421 (mobile)
mergy_mary@lilly.com
https://www.lillyoncologysupport.com
Cyramza (ramucirumab), Alimta (pemetrexed), Erbitux (cetuximab),Retevmo (Selpercatinib), Verzenio (abemaciclib), Portrazza (necitumumab)

Bayer
Jerry George
Field Reimbursement Manager
Bayer Oncology
(716) 308-4143, cell
(585) 492-5261, fax
jerry.george@bayer.com
Xofigo, Nexavar, Nubeqa,Stivarga and Aliqopa

Nexavar Patient Assistance

Stivarga Patient Assistance

Xofigo Patient Assistance 

Aliqopa Patient Assistance

Vitrakvi Patient Assistance
Nubeqa Patient Assistance

Merck
Field Reimbursement
Chris Greklek
M: (202) 253-0592
Email: Christopher.greklek@merck.com

Mark Montello
Medicare Account Executive
Mark.Montello@merck.com
603-321-1145

BeiGene
Jeff Wilhour
Director, Field Market Access
Cell: 410-804-2619
jeff.wilhour@beigene.com
Brukinsa Patient Support
1-833-234-4363
Brukinsa

Novartis Oncology

Elizabeth Gugliotta

Associate Director Access & Reimbursement

Elizabeth.Gugliotta@novartis.com

Cell: 401-480-9905

https://www.hcp.novartis.com

BMS Access Support James Blanchard

Manager, Access & Reimbursement Support
Manchester, NH (ME, NH, VT)
Cell (207) 232-3395
james.blanchard@bms.com
www.BMSAccessSupport.com
www.celgenepatientsupport.com

Oncology
Abraxane, Opdivo, Yervoy

Hematology
Empliciti, Idhifa, Inrebic, Onureg, Pomalyst, Reblozyl, Revlimid, Sprycel

Oncopeptides 
Kelly Draveling
National Account Executive
kelly.draveling@oncopeptides.com
816-522-2032

PEPAXTO (melphalan flufenamide)

www.OnCoursesupport.com

Boehringer-Ingelheim-Gilotrif

Cathy Berry
Reimbursement Access Associate Director
Cell Phone: 716 481 1563
E-mail: catherine.berry@boehringer-ingelheim.com
Gilotrif: https://www.gilotrifhcp.com/starting-your-patient
Gilotrif Commercial Co-Pay 

For more information on the BI Cares Foundation, call 1-855-297-5906 or visit www.boehringer-ingelheim.us/our-responsibility/patient-assistance-program

Clovis Oncology

Katheryne Murray
Practice Experience Manager- Northeast

Cell: 860-876-5568

kmurray@clovisoncology.com

www.rubracaconnections.com

Rubraca® (rucaparib)

Coherus Biosciences, Inc.
Teri Nisbet, CPC, CHONC
Field Reimbursement Specialist
Phone: 727-599-4998
tnisbet@coherus.com
https://www.coheruscomplete.com/

Pharmacyclics
Jason Hart

Field Access Specialist – Northeast

Cell: 603-777-6362

Email: Jason.hart@abbvie.com

IMBRUVICA (ibrutinib) Patient Access & Support Services: www.imbruvicabyyourside.com

Pfizer
Julie Rogers
Field Reimbursement Manager
Pfizer Oncology
860-422-0420
Julie.rogers@pfizer.com

Pfizer Patient Assistance: www.PfizerOncologyTogether.com

Dova Pharmaceuticals

Richard DeBone
Director- Market Access
Dova Pharmaceuticals
rdebone@dova.com
724.953.9661

Puma Biotechnology

Ron Terrill, Senior Clinical Specialist
424-402-9125
rterrill@pumabiotechnology.com
NERLYNX® (neratinib)
https://nerlynx.com/hcp/access-and-support

Eisai
Betsy Clark
Senior Oncology Specialist
Betsy_Clark@eisai.com
Lenvima,Halaven
www.eisaireimbursement.com

Regeneron
Jeanne Leahy
Phone: 215-285-0068
Email: Jeanne.leahy@sanofi.com
Libtayo: Libtayohcp.com
Libtayo: Libtayo Surround

Rigel Pharmaceuticals 

Karen “KB” Sweeting 

Territory Business Manager

ME, NH, VT & Eastern MA

Rigel Pharmaceuticals 

Mobile (916) 708 1078 

EMD Serono

Walter Serafin, MA, BA

Associate Director, Government Programs & Field Reimbursement 

EMD Serono, Inc.

Mobile: (339) 214-6080

Office: (913) 322-6063

walter.serafin@emdserono.com

One Technology Place

Rockland, MA. 02370
EMD Serono’s CoverOne Program
Toll Free (844) 826-8371

Sandoz Biopharmaceuticals
Andrew Palsha
Reimbursement Policy Manager
508 735-1941
andrew.palsha@sandoz.com
https://www.sandozonesource.com/

Epizyme
Kevin M. McKeon
Oncology Account Manager – Epigenetic Therapy
kmckeon@epizyme.com
(603) 759-9201 (cell)
TAZVERIK™ (tazemetostat)

EpizymeNOW Patient and Product Support Enrollment Form or 1-833-4EPINOW (437-4669)

Sanofi-Genzyme Oncology
Mike Brooks
Regional Account Manager
484-686-9380
mike.brooks@sanofi.com

Sarclisa (isatuximab-irfc), Jevtana (Cabazitaxel), Elitek (Raspuricase)

CareASSIST

Exelixis 

Michele Sofarelli Luther

Associate Director, Patient Access

CABOMETYX.com
207-838-2364 
msofarelli@exelixis.com 
Exelixis Access Services

Seagen
Samit Bhatt
Associate Director-US Managed Markets
425-308-0597
sbhatt@seagen.com
www.SeagenSecure.com

Servier
Wendy Poage
Patient Advocacy
Oncaspar, Asparlas
Wendy.Poage@servier.com
617-335-7987

Genentech
Susan Royal
Field Reimbursement Manager
Cell: ​(617) 653-3288
royal.susan@gene.com
https://www.genentech-access.com
copayassistancenow.com
https://www.gene.com/patients/patient-foundation
855-MYCOPAY (855-692-6729)

Infused Products: AVASTIN® (bevacizumab) , GAZYVA® (obinutuzumab)HERCEPTIN® (trastuzumab), KADCYLA® (ado-trastuzumab emtansine), PERJETA® (pertuzumab), POLIVY™ (POLATUZUMAB VEDOTIN-PIIQ), RITUXAN® (rituximab), TECENTRIQ® (atezolizumab)

Oral Products: ALECENSA® (alectinib), COTELLIC® (cobimetinib), ERIVEDGE® (vismodegib),GAVRETO (pralsetinib),ROZLYTREK® (entrectinib), TARCEVA® (erlotinib), VENCLEXTA™ (venetoclax) ZELBORAF® (vemurafenib)

Subcutaneous Products: ​HERCEPTIN HYLECTA™ (TRASTUZUMAB AND HYALURONIDASE-OYSK), ​PHESGO (pertuzumab, trastuzumab, and hyaluronidase-zzxf), RITUXAN HYCELA™ (rituximab/hyaluronidase human)

Stemline Therapeutics
Angela Johnson
Field Reimbursement Manager, Northeast
Cell: 724-858-6285
ajohnson@stemline.com
ELZONRIS
www.elzonris.com
Stemline ARC Patient Assistance

Dan Monteith
Regional Oncogenomic Liaison
Genomic Health
m 650.722.7043 or 866.613.3015
f 603.488.5565
dmonteith@genomichealth.com

Taiho Oncology

Bob Stewart
Director, Market Access
Taiho Oncology, Inc.
101 Carnegie Center, Suite 101
Princeton, NJ 08540
609 575-5169
rstewart@taihooncology.com https://www.taihooncologycopay.com/

Gilead

Melissa McLean
Field Reimbursement Senior Manager (Northeast)
M: (914) 715-7535
Email: melissa.mclean1@gilead.com
Zydelig (idelalisib)
https://www.zydeligaccessconnect.com/patient
1-844-622-2377
Yescarta (axicabtagene ciloleucel)
https://www.yescarta.com/support#kite-konnect

1-844-454-5483

TRODELVY
Access Services: https://trodelvy.com/patient/access-services

Takeda
Deborah Looney
Field Access Director
Ph: 617-543-9736
deborah.looney@takeda.com
Takeda Oncology Here2Assist™

Kate Friday
Director Patient Services

Kate.Friday@tevapharm.com
973-214-8394

US ACT Parsippany, NJ

www.tevacore.com

TG Therapeutics 

Kelly Bucklen

Kelly.bucklen@tgtxinc.com

401.261.5262

www.Ukoniq.com/patientsupport

Ukoniq (Umbralisib)